Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2013 Financial Results

[GlobeNewswire] – — Company Achieves 2013 Net Product Sales of $48.5 Million — 2014 Net Product Sales Expected to be Between $190 and $210 Million — Cash Flow Positive Operations Anticipated in the Second Half of 2014… more

View todays social media effects on AEGR

View the latest stocks trending across Twitter. Click to view dashboard

See who Aegerion is hiring next, click here to view